Commercial
Trust building: Pharma needs to provide information
To overcome its image problem with the public, pharma must open all channels of communication and ensure that the information they provide about their product is fair and balanced.
More Access and Evidence Articles
Commercial
From patient to consumer – healthcare in the digital age
Are digital health platforms set to make a greater impact than the majority of molecules developed over the past 20 years? Nick de Cent investigates.
Access and Evidence
Break with the past to deliver value beyond the pill
Beyond this first wave of product-focused services, there has also been a second; driven by the belief that pharma can actually deliver services as standalone commercial offerings.
Access and Evidence
Pharma needs to lead discussion about reimbursement
The rules governing reimbursement and market access for new products are changing around the world, but one thing remains constant: to get your drug on the formulary, you need to demonstrate value. What’s new is that now pharma needs to take a lead in the discussion.
Commercial
Going “beyond the pill” requires innovation accelerator teams
Providing “beyond the pill” patient solutions requires new organizational structures and mind-sets. Virtual innovation accelerator teams dedicated to the realization of novel commercial projects must replace the “silo” departmental mind-set.
Access and Evidence
Volume to Value: A shift in pharma’s business model
As pharma faces transition from traditional business model to a value-based model, identifying appropriate customers and understanding their needs becomes crucial for each organization.
Access and Evidence
Time for services: Latin America’s enviable position and an opportunity for pharma
Latin America provides pharma with a unique opportunity to get involved with building the healthcare system of the future from the ground up. Soeren Mattke discusses why this is the right time for service-based models and how to make the most of modern technologies in the process.
Access and Evidence
Big Data Will Make Clinical Trials Obsolete
Clinical trials as we know it are over. Their annual cost is unsustainable and solutions that curtail these expenses must be put in place. Luckily, big data offers unprecedented opportunities that will revolutionize research.
Access and Evidence
Big Data Will Revolutionize Clinical Trials
Clinical trials as we know it are over. Their annual cost is unsustainable and solutions that curtail these expenses must be put in place. Luckily, big data offers unprecedented opportunities that will revolutionize research.
Commercial
Patient-Centered Clinics: IVF Spain
IVF Spain is a fertility clinic in Alicante famous for a stellar success rate and high patient-satisfaction, as well as for involving patients in the design of the services, which puts it at the forefront of patient-centricity.